Michael Greiner - 29 Oct 2024 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
Interim CEO
Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol
AVNS
Transactions as of
29 Oct 2024
Transactions value $
$0
Form type
4
Filing time
31 Oct 2024, 15:51:06
Previous filing
19 Mar 2024
Next filing
05 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +44.2K +30.12% $0.00 191K 29 Oct 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest on October 29, 2025, provided that if the Reporting Person's employment is terminated without cause prior to such date, all the TRSUs will vest immediately. Each TRSU is the economic equivalent of one share of Common Stock.